Trump unveils Regeneron deal to lower drug prices
Summary
President Donald Trump announced a deal with the drug company Regeneron to voluntarily lower drug prices. This is the last drug maker to agree to the White House’s plan to reduce medicine costs in the U.S. to levels similar to other developed countries.Key Facts
- President Trump revealed a pricing agreement with Regeneron on Thursday.
- Regeneron will lower prices on current and future medicines it sells in the U.S.
- This deal completes the White House’s “most favored nation” plan involving drug companies.
- The “most favored nation” plan aims to match U.S. drug prices with those in other developed countries.
- Regeneron is the last pharmaceutical manufacturer to join this price-cutting effort.
- The plan is voluntary for drug companies but encouraged by the White House.
- The goal is to make medications more affordable for American patients.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.